Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 19

1.

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer.

Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Zannettino AC, Findlay DM, Evdokiou A.

Mol Cancer Ther. 2009 Oct;8(10):2969-80. doi: 10.1158/1535-7163.MCT-09-0745. Epub 2009 Oct 6.

2.

Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes.

Edgington LE, Berger AB, Blum G, Albrow VE, Paulick MG, Lineberry N, Bogyo M.

Nat Med. 2009 Aug;15(8):967-73. doi: 10.1038/nm.1938. Epub 2009 Jul 13.

3.

Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.

Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M.

Nat Chem Biol. 2007 Oct;3(10):668-77. Epub 2007 Sep 9.

PMID:
17828252
4.

Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.

Berger AB, Witte MD, Denault JB, Sadaghiani AM, Sexton KM, Salvesen GS, Bogyo M.

Mol Cell. 2006 Aug;23(4):509-21.

5.

Lighting up tumors with receptor-specific optical molecular probes.

Achilefu S.

Technol Cancer Res Treat. 2004 Aug;3(4):393-409. Review.

PMID:
15270591
6.

Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death.

Toretsky J, Levenson A, Weinberg IN, Tait JF, Uren A, Mease RC.

Nucl Med Biol. 2004 Aug;31(6):747-52.

PMID:
15246365
7.

Recent advances in the imaging of programmed cell death.

Blankenberg FG.

Curr Pharm Des. 2004;10(13):1457-67. Review.

PMID:
15134569
8.
9.

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Ntziachristos V, Bremer C, Weissleder R.

Eur Radiol. 2003 Jan;13(1):195-208. Epub 2002 Jul 19. Review.

PMID:
12541130
10.

Apoptosis in cardiac disease--what is it--how does it occur.

Neuss M, Crow MT, Chesley A, Lakatta EG.

Cardiovasc Drugs Ther. 2001 Nov;15(6):507-23. Review.

PMID:
11916360
11.

Will imaging of apoptosis play a role in clinical care? A tale of mice and men.

Blankenberg FG, Strauss HW.

Apoptosis. 2001 Feb-Apr;6(1-2):117-23. Review.

PMID:
11321034
12.

Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V.

Lahorte C, Slegers G, Philippé J, Van de Wiele C, Dierckx RA.

Biomol Eng. 2001 Jan;17(2):51-3.

PMID:
11163751
13.

Apoptosis: the importance of nuclear medicine.

Blankenberg FG, Tait J, Ohtsuki K, Strauss HW.

Nucl Med Commun. 2000 Mar;21(3):241-50. Review.

PMID:
10823326
14.

Death by design: mechanism and control of apoptosis.

Song Z, Steller H.

Trends Cell Biol. 1999 Dec;9(12):M49-52. Review.

PMID:
10611682
15.

Evaluation of annexin V as a platelet-directed thrombus targeting agent.

Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K, Ritchie JL, Stratton JR.

Thromb Res. 1994 Sep 1;75(5):491-501.

PMID:
7992250
16.

Apoptosis in the pathogenesis and treatment of disease.

Thompson CB.

Science. 1995 Mar 10;267(5203):1456-62. Review.

PMID:
7878464
17.

Mechanisms and genes of cellular suicide.

Steller H.

Science. 1995 Mar 10;267(5203):1445-9. Review.

PMID:
7878463
18.

The complexity of the phospholipid binding protein Annexin V.

van Heerde WL, de Groot PG, Reutelingsperger CP.

Thromb Haemost. 1995 Feb;73(2):172-9. Review. No abstract available.

PMID:
7792726

Supplemental Content

Support Center